Zevacor   Report issue

For profit Phase 3
Founded: Noblesville IN United States (1986)
Status: Acquired by Sofie (2017)

Organization Overview

First Clinical Trial
2014
NCT02260817
First Marketed Drug
2014
fludeoxyglucose f-18
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GLOBAL ISOTOPES LLC

Active Ingredients

Marketed Drugs (4)

ammonia n-13 (2014)

choline c11 (choline c-11) (2015)

fludeoxyglucose f-18 (2014)

sodium fluoride (18F) (2014)

Drugs in Phase 3 Trials (1)

choline c11 (choline c-11) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1